Global Pharmaceuticals & Biotech High Quality Undervalued Stocks

Chugai Pharmaceutical

Market Cap: JP¥11.4t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Galderma Group

Market Cap: CHF 40.3b

Operates as a dermatology company worldwide.

Innovent Biologics

Market Cap: HK$163.3b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

WuXi XDC Cayman

Market Cap: HK$78.6b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$65.7b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

Ligand Pharmaceuticals

Market Cap: US$5.9b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

BioGaia

Market Cap: SEK 11.4b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Viyash Scientific

Market Cap: ₹111.6b

Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.

Strides Pharma Science

Market Cap: ₹89.2b

A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.